A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge

Vaccine

Volumn 29, Issue 34, 2011, Pages 5623-5630

  Pallister, Jackie ^a   Middleton, Deborah ^a   Wang, Lin Fa ^a   Klein, Reuben ^a   Haining, Jessica ^a   Robinson, Rachel ^a   Yamada, Manabu ^b   White, John ^a   Payne, Jean ^a   Feng, Yan Ru ^c   Chan, Yee Peng ^c   Broder, Christopher C ^c  

^a CSIRO   (Australia)

^b NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Glycoprotein G; Hendra virus; Subunit vaccine; Vaccination

Indexed keywords

RECOMBINANT GLYCOPROTEIN GP 120; SUBUNIT VACCINE; THROMBOSPONDIN;

ARTICLE; BODY FLUID; CONTROLLED STUDY; CPG ISLAND; FATALITY; FERRET; HENDRA VIRUS INFECTION; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS GENOME; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, VIRAL; FERRETS; GLYCOPROTEINS; HENDRA VIRUS; HENIPAVIRUS INFECTIONS; RECOMBINANT PROTEINS; VACCINES, SUBUNIT; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES; VIRUS SHEDDING;

EID: 79960563109     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.06.015     Document Type: Article

References (36)

1. Williamson M.M., Torres-Velez F.J. Henipavirus: a review of laboratory animal pathology. Vet Pathol 2010, 47(5):871-880.
2. Murray K., Selleck P., Hooper P., Hyatt A., Gould A., Gleeson L., et al. A morbillivirus that caused fatal disease in humans and horses. Science 1995, 268:94-97.
3. Marsh G.A., Todd S., Foord A., Hansson E., Davies K., Wright L., et al. Genome sequence conservation of Hendra virus isolates during spillover to horses. Aust Emerg Infect Dis 2010, 16:1767-1769.
4. Eaton B.T., Mackenzie J.S., Wang L.F. Henipaviruses. Fields virology 2007, 1587-1600. Lippincott & Wilkins, Philadelphia. 5th ed. D.M. Knipe, P.M. Howley (Eds.).
5. Wang L.F., Yu M., Hansson E., Pritchard I., Shiell B., Michalski W.P., et al. The exceptionally large genome of Hendra virus: support for creation of a new genus within the family Paramyxoviridae. J Virol 2000, 74:9972-9979.
6. Chua K.B., Bellini W.J., Rota P.A., Harcourt B.H., Tamin A., Lam S.K., et al. Nipah virus: a recently emergent deadly Paramyxovirus. Science 2000, 288:1432-1435.
7. Luby S.P., Gurley E.S., Hossain M.J. Transmission of human infection with Nipah virus. Clin Infect Dis 2009, 49:1743-1748.
8. Anonymous. Nipah encephalitis, human - Bangladesh. International society for infectious diseases; 2011 (02) 20110214.0495.
9. Blum L.S., Khan R., Nahar N., Breiman R.F. In-depth assessment of an outbreak of Nipah encephalitis with person-to-person transmission in Bangladesh: implications for prevention and control strategies. Am J Trop Med Hyg 2009, 80:96-102.
10. Gurley E.S., Montgomery J.M., Hossain M.J., Bell M., Azad A.K., Rafi qul Islam M., et al. Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis 2007, 13:1031-1037.
11. Homaira N., Rahman M., Hossain M.J., Epstein J.H., Sultana R., Khan M.S., et al. Nipah virus outbreak with person-to-person transmission in a district of Bangladesh, 2007. Epidemiol Infect 2010, 138:1630-1636.
12. Bossart K.N., Broder C.C. Paramyxovirus entry. Viral Entry into Host Cells 2009, Landes Bioscience, Austin, TX. S. Pöhlmann, G. Simmons (Eds.).
13. Bonaparte M.I., Dimitrov A.S., Bossart K.N., Crameri G., Mungall B.A., Bishop K.A., et al. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad Sci U S A 2005, 102:10652-10657.
14. Negrete O.A., Levroney E.L., Aguilar H.C., Bertolotti-Ciarlet A., Nazarian R., Tajyar S., et al. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 2005, 436:401-405.
15. Negrete O.A., Wolf M.C., Aguilar H.C., Enterlein S., Wang W., Muhlberger E., et al. Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus. PLoS Pathog 2006, 2:e7.
16. Bishop K.A., Stantchev T.S., Hickey A.C., Khetawat D., Bossart K.N., Krasnoperov V., et al. Identification of Hendra virus G glycoprotein residues that are critical for receptor binding. J Virol 2007, 81:5893-5901.
17. Pasquale E.B. Eph-ephrin bidirectional signaling in physiology and disease. Cell 2008, 133:38-52.
18. Graham B.S., Crowe J.E. Immunization against viral diseases. Fields virology 2007, 487-538. Lippincott & Wilkins, Philadelphia. 5th ed. D.M. Knipe, P.M. Howley (Eds.).
19. Wolinsky J.S., Waxham M.N., Server A.C. Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis. J Virol 1985, 53:727-734.
20. Plotkin S.A. Vaccination against the major infectious diseases. CR Acad Sci III 1999, 322:943-951.
21. Bossart K.N., Zhu Z., Middleton D., Klippel J., Crameri C., Bingham J., et al. A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute Nipah virus infection. PLoS Pathog 2009, 5:1-11.
22. Guillaume V., Contamin H., Loth P., Georges-Courbot M.C., Lefeuvre A., Marianneau P., et al. Nipah virus: vaccination and passive protection studies in a hamster model. J Virol 2004, 78:834-840.
23. Guillaume V., Contamin H., Loth P., Grosjean I., Courbot M.C., Deubel V., et al. Antibody prophylaxis and therapy against Nipah virus infection in hamsters. J Virol 2006, 80:1972-1978.
24. Guillaume V., Wong K.T., Looi R.Y., Georges-Courbot M.C., Barrot L., Buckland R., et al. Acute Hendra virus infection: analysis of the pathogenesis and passive antibody protection in the hamster model. Virology 2009, 387:459-465.
25. Weingartl H.M., Berhane Y., Caswell J.L., Loosmore S., Audonnet J.C., Roth J.A., et al. Recombinant Nipah virus vaccines protect pigs against challenge. J Virol 2006, 80:7929-7938.
26. McEachern J.A., Bingham J., Crameri G., Green D.J., Hancock T.J., Middleton D., et al. A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats. Vaccine 2008, 26:3842-3852.
27. Mungall B.A., Middleton D., Crameri G., Bingham J., Halpin K., Russell G., et al. Feline model of acute Nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine. J Virol 2006, 80:12293-12302.
28. Wild T.F. Henipaviruses A new family of emerging Paramyxoviruses. Pathol Biol (Paris) 2009, 57:188-196.
29. Pallister J., Middleton D., Crameri G., Yamada M., Klein R., Hancock T.J., et al. Chloroquine administration does not prevent Nipah virus infection and disease in ferrets. J Virol 2009, 83:11979-11982.
30. Middleton D.J., Westbury H.A., Morrissy C.J., van der Heide B.M., Russell G.M., Braun M.A., et al. Experimental Nipah virus infection in pigs and cats. J Comp Pathol 2002, 126:124-136.
31. Feldman K.S., Foord A., Heine H.G., Smith I.L., Boyd V., Marsh G.A., et al. Design and evaluation of consensus PCR assays for henipaviruses. J Virol Methods 2009, 161:52-57.
32. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real time quantitative PCR and the 2-ΔΔCT method. Methods 2001, 25:402-408.
33. Bossart K.N., McEachern J.A., Hickey A.C., Choudhry V., Dimitrov D.S., Eaton B.T., et al. Neutralization assays for differential henipavirus serology using Bio-Plex Protein Array Systems. J Virol Methods 2007, 142:29-40.
34. Zitzow L.A., Rowe T., Morken T., Shieh W.J., Zaki S., Katz J.M. Pathogenesis of avian influenza A (H5N1) viruses in ferrets. J Virol 2002, 76:4420-4429.
35. Martina B.E.E., Haagmans B.L., Kuiken T., Fouchier R.A.M., Rimmelzwaan G.F., van Amerongen G., et al. SARS virus infection of cats and ferrets. Nature 2003, 425:915.
36. O'Sullivan J.D., Allworth A.M., Paterson D.L., Snow T.M., Boots R., Gleeson L.J., et al. Fatal encephalitis due to novel paramyxovirus transmitted from horses. Lancet 1997, 349:93-95.